The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene Mutation–Extraordinary Results With Sotorasib

Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles. Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated June 6th, 2022

The First Targeted Therapy For Lung Cancer Patients With The KRAS Gene Mutation–Extraordinary Results With Sotorasib

NOW
PLAYING
'Game-Changing' Drug Enhertu Now Approved for Certain Types of Lung Cancer — What Does This Mean for Patients?
NOW
PLAYING
Hungry Kathy Griffin, 61, Dishes On Zucchini Sticks Vs. A 'Vegetable Medley' Her Husband, 38, Made Her: ‘Which One Do You Think I Ate?’
NOW
PLAYING
Combining Treatments for Esophageal Cancer
NOW
PLAYING
What is HER2 Classification of Breast Cancer?
NOW
PLAYING
Finally Some Progress For Esophageal Cancer Patients - New Immunotherapy Drugs Are Boosting Survival
NOW
PLAYING
Von Hippel-Lindau: Epididymal Cystadenomas
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.